Sangamo Therapeutics
SGMO
#10621
Rank
ยฃ23 M
Marketcap
ยฃ0.05553
Share price
0.00%
Change (1 day)
-87.50%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -ยฃ82.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ34.55 Million. In 2025 the company made an earning of -ยฃ81.06 Million a decrease over its 2024 earnings that were of -ยฃ73.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ82.12 Million1.31%
2025 -ยฃ81.06 Million9.71%
2024 -ยฃ73.89 Million-17.27%
2023 -ยฃ89.3 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ97.23 Million23.17%
2019 -ยฃ78.94 Million36.33%
2018 -ยฃ57.9 Million36.89%
2017 -ยฃ42.3 Million-22.32%
2016 -ยฃ54.46 Million54.86%
2015 -ยฃ35.17 Million75.62%
2014 -ยฃ20.03 Million0.13%
2013 -ยฃ20 Million
2011 -ยฃ26.89 Million43.66%
2010 -ยฃ18.72 Million28.52%
2009 -ยฃ14.57 Million-23.55%
2008 -ยฃ19.05 Million2.45%
2007 -ยฃ18.59 Million19.5%
2006 -ยฃ15.56 Million50.78%
2005 -ยฃ10.32 Million75%
2004 -ยฃ5.9 Million-33.25%
2003 -ยฃ8.84 Million-62.27%
2002 -ยฃ23.41 Million102.82%
2001 -ยฃ11.55 Million23.21%
2000 -ยฃ9.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.66 B-23,855.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ7.71 B-9,424.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ0.75 B-1,016.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ0.75 Billion 803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ1.47 Billion 1,672.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.77 B-7,070.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.84 B-1,119.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.11 B-235.16%๐Ÿ‡บ๐Ÿ‡ธ USA